Charles River Laboratories | Passivo Circulante



Current Liabilities Alterar Data
Agilent USD 1.87B 26M 2025-01
Align Technology USD 1.99B 47.08M 2025-03
Bio-Rad Laboratories USD 467.8M 30.14M 2024-12
Bruker USD 1.28B 37.5M 2024-12
Cardinal Health USD 35.22B 545M 2024-12
Charles River Laboratories USD 994.1M 18.12M 2024-12
Cigna USD 57.98B 919M 2024-12
CVS Health USD 84.61B 18M 2024-12
Danaher USD 6.64B 153M 2025-03
Dentsply International USD 1.59B 47M 2024-12
Elevance Health 40.36B 1.67B 2024-12
Galapagos EUR 437.04M 101.96M 2025-03
Hologic USD 1B 34.8M 2024-12
Humana 16.94B 1.79B 2024-12
Illumina USD 1.55B 572M 2024-12
Incyte USD 1.89B 244.96M 2025-03
IQVIA Holdings USD 6.96B 35M 2024-12
Laboratory Of America USD 2.06B 1.27B 2025-03
Lonza CHF 3.58B 970M 2024-12
McKesson USD 58.56B 209M 2024-12
Merck EUR 11.29B 831M 2024-12
Mettler Toledo International USD 1.17B 16.77M 2024-12
Novartis USD 28.69B 560M 2024-12
Pfizer USD 43B 216M 2024-12
Quest Diagnostics USD 1.44B 728M 2025-03
Revvity USD 648.19M 4.91M 2025-03
Thermo Fisher Scientific USD 13.17B 158M 2025-03
United Therapeutics USD 721.5M 16.6M 2025-03
UnitedHealth 103.77B 2.2B 2024-12
Walgreens Boots Alliance USD 26.58B 868M 2025-02
Waters USD 789.76M 26.28M 2024-12
West Pharmaceutical Services USD 526.7M 23.7M 2025-03



Charles River Laboratories Passivo Circulante - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - May 2025.